Skip to main content
High RiskFDAfda-H-0535-2025UNDECLARED ALLERGEN

Baker's Authority Graham Cracker Meal; 5lb bag; stored dry at room temperature; packaged in silver bag

Units Affected
70
Recall Date
August 12, 2025
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0535-2025.

Product label does not list ingredients including major food allergens: wheat and soy (vegetable oil). Additional undeclared ingredients include: niacin, reduced iron, vitamin B1, vitamin B2, invert sugar

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0535-2025.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Bakers Authority Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0535-2025.

Bakers Authority LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Bakers Authority Llc Recall FAQ

Bakers Authority Llc is the subject of a bakery & grains safety report: Baker's Authority Graham Cracker Meal; 5lb bag; stored dry at room temperature; packaged in silver bag. The notice was published on August 12, 2025 by the U.S. Food and Drug Administration (FDA). Approximately 70 units are potentially affected.